Skip to main content

Table 1 Metformin did not influence blood gas, glucose level and body weight in transient middle cerebral artery occlusion (tMCAO) mice

From: Metformin attenuates blood-brain barrier disruption in mice following middle cerebral artery occlusion

 

Before tMCAO

After tMCAO

 

NS

Met

NS

Met

pH

7.35 ± 0.05

7.34 ± 0.03

7.34 ± 0.07

7.35 ± 0.03

PCO2 (mmHg)

38 ± 5

33 ± 3

30 ± 7

30 ± 5

PO2 (mmHg)

62 ± 4

60 ± 7

64 ± 2

66 ± 12

SO2 (%)

91 ± 8%

87 ± 10%

91 ± 2%

91 ± 5%

Na(mmol/L)

155 ± 2

153 ± 2

154 ± 3

152 ± 2

K (mmol/L)

3.2 ± 0.1

3.1 ± 0.4

3.5 ± 0.3

3.9 ± 0.2

iCa (mmol/L)

1.37 ± 0.02

1.34 ± 0.06

1.22 ± 0.04

1.26 ± 0.04

Glu (mg/dL)

132 ± 20

127 ± 33

123 ± 16

129 ± 24

Hct (%PCV)

37 ± 1%

35 ± 1%

34 ± 6%

35 ± 2%

Hb (g/dL)

12.4 ± 0.4

11.9 ± 0.3

11.4 ± 2.2

11.8 ± 0.7

Body weight (g)

33 ± 2

32 ± 1

25 ± 6

28 ± 4

  1. Table showed vein blood gas analysis results, glucose levels and body weight at 1 day before tMCAO and at 3 days after tMCAO in metformin-(Met) and saline(NS)-treated mice (n =4 per group). Data were mean ± SD.
  2. Legend: Glu, glucose; Hb, hemoglobin; Hct, hematocrit; PCO2, partial pressure of CO2; PO2, partial pressure of O2; PCV, packed cell volume; SO2, oxygen saturation.